Drug information for HALFLYTELY
| Form
| Dosage
| Status
| Therapeutic Equivalence
| Active Ingred
| Ref.
| Sponsor
| Document
|
| TABLET, DELAYED RELEASE, FOR SOLUTION; ORAL
| 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM
| Prescription
| (Reference Drug)
| BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
| laxadine
| BRAINTREE
| 21551
2011-07-12 Letter
2010-08-05 Other
2010-07-30 Medication Guide
2010-07-23 Letter
2010-07-19 Label
2007-09-26 Label
2007-09-26 Letter
2006-05-22 Label
2006-05-21 Letter
2005-12-01 Review
2005-03-03 Letter
2004-05-27 Label
2004-05-26 Letter |
| TABLET, DELAYED RELEASE, FOR SOLUTION; ORAL
| 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM
| Discontinued
|
| BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
| laxadine
| BRAINTREE
| " |
Drug Adverse Effects information for HALFLYTELY
|